Search By Initial

Cas Index 2

• 256414-75-2 | SEW2871 (Catalog# : 20604)SEW2871 is a S1P1 agonist (sphingosine-1-phosphate type 1 receptor agonist). SEW2871
• 2765525-82-2 | STX-721 (Catalog# : 20576)STX-721 is a next-generation, orally delivered therapy, designed with potential best-
• 2648257-56-9 | STC-15 (Catalog# : 20549)STC-15 is a first-in-class inhibitor of RNA modification and is the first ever RNA me
• 2921961-53-5 | (S)-5-fluoro-3-methylbenzo[c][1,2]oxaborol-1(3H)-ol (Catalog# : 20522)
• 2170746-98-0 | Spiro[cyclohexane-1,9'(6'H)-pyrazino[1',2':1,5]pyrrolo[2,3-d]pyrimidine]-7'(8'H)-carboxylic acid, 2'-(methylthio)-6'-oxo-5'-[[(trifluoromethyl)sulfonyl]oxy]-, 1,1-dimethylethyl ester (Catalog# : 20412)
• 2322245-42-9 (free base) | SRI-37330 free base (Catalog# : 1711224)SRI-37330 is a novel inhibitor of TXNIP expression, decreasing glucagon secretion and
• 2370013-12-8 | Sunvozertinib ( DZD 9008 ) (Catalog# : 20369)Sunvozertinib, also known as DZD9008, is an oral, potent, irreversible, and selective
• 2102681-49-0 | SHMT-IN-2 (Catalog# : 20368)SHMT-IN-2 is a serine hydroxymethyltransferase (SHMT) inhibitor, potently inhibiting
• 2582757-90-0 | Stafia-1 (Catalog# : L20338)
• 2499663-01-1 | STM2457 (Catalog# : 20321)STM2457 is a highly potent and selective first-in-class catalytic inhibitor of METTL3
• 2322245-49-6 | SRI-37330 HCl (Catalog# : 20306)SRI-37330 hydrochloride is a novel inhibitor of TXNIP expression,and dose-dependently
• 2089251-47-6 | SM-102 (Catalog# : 21252)SM-102 is an ionizable amino lipid that has been used in combination with other lipid
• 287383-59-9 | Scriptaid (Catalog# : 21229)Scriptaid, also known as GCK 1026, is a HDAC inhibitor. Scriptaid protects against tr
• 2351882-11-4 | Spastazoline (Catalog# : 2071521)Spastazoline is a novel inhibitor for aaa+ (atpases associated with diverse cellular
• 296280-56-3 | S26131 (Catalog# : 112592)S26131 is a bioactive chemical.
• 2195361-33-0 | SPL-707 (Catalog# : 193209)SPL-707 is the first selective and orally active SPPL2a inhibitor. It shows adequate
• 2055757-40-7 | SHP394 (Catalog# : 193122)SHP394 is a potent and orally active SHP2 inhibitor (IC50 = 23 nM) with high lipophil
• 2226517-76-4 | SGC-GAK-1 (Catalog# : 193113)SGC-GAK-1 is a potent and selective GAK kinase probe which targets the ATP-binding si
• 2152628-33-4 | Selpercatinib (Catalog# : 192276)Selpercatinib is a tyrosine kinase inhibitor with antineoplastic properties.
• 254740-64-2 | Sparsentan (Catalog# : 1812132)Sparsentan, also known as RE-021, PS433540 and DARA-a, is a Dual angiotensin II and e
• 205678-31-5 | SB-273005 (Catalog# : 186221)SB-273005 is an inhibitor of integrin αvβ3.
• 2097334-20-6 | (S)-3-(tert-butoxycarbonyl)-2-(4-((2,4-dimethylbenzoyloxy)methyl)phenyl)propanoic acid (Catalog# : 183218)(S)-3-(tert-butoxycarbonyl)-2-(4-((2,4-dimethylbenzoyloxy)methyl)phenyl)propanoic aci
• 2070015-26-6 | SRT3025 HCl (Catalog# : 17101310)SRT3025 is an orally available small molecule activator of the SIRT1 enzyme.
• 271576-80-8 | SD-06 (Catalog# : 1791320)SD-06 is a MAPK p38 alpha inhibitor for the treatment of arthritis.
• 215543-92-3 | SU5402 (Catalog# : 174191)SU5402 is a fibroblast growth factor receptor (FGFR)-specific tyrosine kinase inhibit
• 201677-61-4 | Sivelestat sodium (Catalog# : 16122758)Sivelestat sodium is a competitive inhibitor of human neutrophil elastase, also inhib
• 2070015-29-9 | SJB3-019A (Catalog# : 611930)SJB3-019A is a potent and novel usp1 inhibitor. SJB3-019A (IC50 = 0.0781 uM) was 5 ti
• 280744-09-4 | SB-216763 (Catalog# : 161009026)SB-216763 is a glycogen synthase kinase-3 (GSK3) inhibitor, which can maintain mouse
• 287383-59-9 | Scriptid (Catalog# : 16071007)Scriptid
• 223104-29-8 | SEA0400 (Catalog# : 16070911)SEA0400 is a Na+/Ca2+ exchanger 1 inhibitor. SEA0400 prevents dopaminergic neurotoxic